Phase 4 Newly Diagnosed Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).
Acute Myeloid LeukemiaChemotherapy EffectNewly Diagnosed
Fujian Medical University Union Hospital100 enrolled1 locationNCT07561892
Recruiting
Phase 4
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
Newly Diagnosed
The First Affiliated Hospital of Soochow University59 enrolled1 locationNCT06409702
Recruiting
Phase 4
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment
Fujian Medical University Union Hospital580 enrolled1 locationNCT05520892
Recruiting
Phase 4
The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab
Newly Diagnosed Glioblastoma
Medical University of Silesia36 enrolled1 locationNCT05235737